DermTech, Inc. (DMTK)

18d ago, source: Yahoo Finance

SAN DIEGO, April 18, 2024--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the ...

What Analysts Are Saying About DermTech Stock

16d ago, source:

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

BTIG Downgrades DermTech (DMTK)

16d ago, source: Fintel on MSN

Fintel reports that on April 19, 2024, BTIG downgraded their outlook for DermTech (NasdaqCM:DMTK) from Buy to Neutral.

DermTech to Explore Strategic Alternatives and Implement Restructuring Plan

17d ago, source: Stockhouse

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board ...

DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

1mon ago, source: Nasdaq

SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today ...

What Analysts Are Saying About DermTech Stock

16d ago, source: Benzinga.com

Stay well-informed and make prudent decisions using our Ratings Table. DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non ...

DermTech to Explore Strategic Alternatives and Implement Restructuring Plan

17d ago, source: Morningstar

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its ...